Long-term outcome of randomized clinical trial between polyacrylate-polyalcohol copolymer (PPC) and dextranomer-hyaluronic acid copolymer (Dx/HA) as bulking agents for endoscopic treatment of primary vesicoureteral reflux (VUR).

Abstract

The aim of our study is to compare long-term outcome of endoscopic treatment of VUR using PPC or Dx/HA. From October 2014 to April 2017 patients with VUR grades from 3 to 5 that needed endoscopic treatment were eligible for this RCT. Patients were randomized in two groups: PPC and Dx/HA. A VCUG was performed at 6months; if VUR > 3 was still present a second ET was performed. We included for this long-term follow-up study those patients that were successfully treated at short-term follow-up. At 36months postoperative VCUG was performed to assessoutcome. Success was considered if postoperative VUR grade was 0 at 36months, and there was no ureteral obstruction. In the previous study, 60/73 ureters were successfully treated in 36/44 patients, and then we have analyzed 60 ureters in 36 patients. Three patients were lost in long-term follow-up, and then we analyzed 57 ureters in 33 patientsdivided. PPC group 18 patients (28 ureters); and Dx/HA group 15 patients (29 ureters). After 3years of follow-up the VCUG showed a success rate of 26/28 of RU in PPC and 26/29 of DX/HA. Two RU in PPC group had ureteral obstruction, and then the successful rate for PPC group dropped to 24/28. The overall successful rate at long-term was 72.7% of the RU in PPC group and 70.3% in Dx/HA group. PPC and Dx/HA has similar long-term outcome in VUR resolution, butureteral obstruction could be present at long-term follow-up in PPC group.